Skip to Content
Merck
All Photos(1)

Key Documents

SML2260

Sigma-Aldrich

Taspoglutide trifluoroacetate salt

≥95% (HPLC)

Synonym(s):

8-(2-Methylalanine)-35-(2-methylalanine)-36-L-argininamide-7-36-glucagon-like peptide I (human) trifluoroacetate salt, BIM 51077 trifluoroacetate salt, R1583 trifluoroacetate salt, RO 5073031 trifluoroacetate salt, [Aib8,35]hGLP-1(7-36)NH2; H-His-2-methyl-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-2-methyl-Ala-Arg-CONH2 trifluoroacetate salt

Sign Into View Organizational & Contract Pricing

Select a Size

5 MG
€90.00
25 MG
€292.00

€90.00

Please contact Customer Service for Availability
Request a Bulk Order
All Photos(1)

Select a Size

Change View
5 MG
€90.00
25 MG
€292.00

About This Item

Empirical Formula (Hill Notation):
C152H232N40O45 · xC2HF3O2
CAS Number:
275371-94-3
Molecular Weight:
3339.71 (free base basis)
UNSPSC Code:
51111800
NACRES:
NA.77

€90.00

Please contact Customer Service for Availability
Request a Bulk Order

Assay

≥95% (HPLC)

form

lyophilized powder

color

white to beige

shipped in

wet ice

storage temp.

−20°C

Biochem/physiol Actions

Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist. Taspoglutide improves glucose tolerance, postprandial glucose, body weight, glycaemic control and insulin sensitivity in the Zucker diabetic fatty rat.
long-acting glucagon-like peptide 1 (GLP-1) receptor agonist

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000249135
0000316168

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

E Sebokova et al.
Diabetes, obesity & metabolism, 12(8), 674-682 (2010-07-02)
Glucagon-like peptide-1 (GLP-1) receptor agonists are a novel class of pharmacotherapy for type 2 diabetes. We investigated the effects of a novel, long-acting human GLP-1 analogue, taspoglutide, in the Zucker diabetic fatty (ZDF) rat, an animal model of type 2
K Pabreja et al.
British journal of pharmacology, 171(5), 1114-1128 (2013-07-31)
The incidence of type 2 diabetes in developed countries is increasing yearly with a significant negative impact on patient quality of life and an enormous burden on the healthcare system. Current biguanide and thiazolidinedione treatments for type 2 diabetes have
S R K Seshasai et al.
Diabetes, obesity & metabolism, 17(5), 505-510 (2015-02-07)
To study the short-term cardiovascular effects of the once-weekly glucagon-like peptide-1 receptor agonist taspoglutide. We conducted a meta-analysis of individual-participant data from nine randomized controlled trials in the T-Emerge programme, which assessed the efficacy and safety of taspoglutide in type

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service